Neogen Corporation Other Nonoperating Expense
Neogen Corporation (NEOG) reported Other Nonoperating Expense of $372.00 thousand for the 3-month period ending 2022-08-31, per its 10-Q filed 2022-09-30.
Discontinued › Income Statement › Other Income
us-gaap:OtherNonoperatingExpense · last filed 2022-09-30
- Neogen Corporation other nonoperating expense for the quarter ending 2022-08-31 was $372.00K, a 68.33% increase year-over-year.
- Neogen Corporation other nonoperating expense for the quarter ending 2022-02-28 was $48.00K, a 47.25% decline year-over-year.
- Neogen Corporation other nonoperating expense for the quarter ending 2021-08-31 was $221.00K.
- Neogen Corporation other nonoperating expense for the quarter ending 2021-02-28 was $91.00K.
| Period end | Other Nonoperating Expense 3 month | Other Nonoperating Expense 9 month |
|---|---|---|
| 2022-08-31 | $372.00K 10-Q · filed 2022-09-30 | |
| 2022-02-28 | $48.00K 10-Q · filed 2022-04-01 | $34.00K 10-Q · filed 2022-04-01 |
| 2021-08-31 | $221.00K 10-Q · filed 2022-09-30 | |
| 2021-02-28 | $91.00K 10-Q · filed 2022-04-01 | $363.00K 10-Q · filed 2022-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |